HD-OPM Archive
Hashtags

#select

3 posts

Semaglutide cut inflammation 38% in SELECT; biggest drops tracked with fewer events

Aug 21, 2026 · Louis Nervegna ♥ 20 · 💬 4 GLP-1 drugs (semaglutide, tirzepatide)

A new analysis of the SELECT trial asks why semaglutide reduced cardiovascular events. Inflammation markers fell 38% versus placebo, early and even in people who lost little weight, and those with the biggest drops had the fewest events. Modelling suggests part of the drug's benefit runs through lower inflammation, though this shows a link rather than proof of cause.